Clínica Pró-Coração
São Paulo, 05021010, Brazil
NCT Number: NCT07007377
During the flu-like syndrome, the cardiovascular risk is increased, especially in the elderly. Understanding whether blood pressure assessment during an exercise test can aid in the understanding of patient outcomes, thereby improving prognostic ability in clinical practice, is the focus of the present study. Therefore, the aim of this study is to evaluate the hemodynamic response of adults with flu-like symptoms, both vaccinated and unvaccinated, and to conduct a 30-day follow-up for assessment. Patients who are indicated for an ergometric test and present with flu-like syndrome will be selected. We will inquire about their vaccination history and perform the ergometric test to evaluate test duration, arrhythmias, and ischemias
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
São Paulo, 05021010, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Follow-up
Time frame: 1 month
The investigators will analyze whether different responses to exertion, such as blood pressure disorders, are more evident in individuals with or without symptoms who have or have not been vaccinated.
Time frame: 7 and 14 days after treadmill exercise test
The investigators will document whether the symptoms are present or not.
University of Sao Paulo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06387511
Immunization Coverage, Infections
Damaturu, Yobe State, Nigeria
View Trial DetailsNCT03587610
Vaccination
Le Mans, France
View Trial DetailsNCT01054053
Vaccination
Neufchâtel-en-Bray, France
View Trial DetailsNCT04936776
Hematologic Diseases, Hemic and Lymphatic Diseases
New York, United States
View Trial Details